Latest Videos

The ability to rapidly determine if a patient has an infectious disease and what type of treatment the infection will respond to, would significantly reduce the treatment decision time, shorten the impact of symptoms, and minimize transfer to others.

Paul Collinson, St Georges Healthcare NHS Trust, speaking at Point of Care Diagnostics 2015

The High Throughput Biomedicine unit at FIMM Technology Centre provides a wide range of biomedical high throughput assays.

This presentation will outline key issues in oncology biomarker testing and describe findings from a study of practices used by National Cancer Institute (NCI) designated cancer centers, the leading U.S. oncology institutions, for testing key biomarkers in three solid tumors - breast, gastroesophageal and non-small cell lung cancers.

Katja Arndt, University of Potsdam, speaking at Discovery Chemistry Congress 2015.

The chip-system is capable of extracting miRNAs from tumor cell cultures, fresh frozen cells and archive material samples by on-chip gel electrophoresis.

Frank Vollmer discusses a technique using a single DNA oligonucleotide receptor and to follow its successive interactions with DNA molecules in a sample solution.

The development of organic reactions and bio-organic structures relevant for surfaces will be discussed.

A lab-on-a-chip system called the "Fraunhofer ivD-platform" has been established which opens up the possibility for an on-site analysis at low costs.

Centrifugal microfluidics enables efficient miniaturization, integration, parallelization and automation of biochemical assays especially for Point-of-Care applications.